The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 27
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte KNOX VAN DYKE
__________
Appeal No. 1999-2523
Application No. 08/475,791
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, ADAMS and MILLS, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 57-62 and 64-67, which are all the claims
pending in the application.
Claim 57 is illustrative of the subject matter on appeal and is reproduced
below:
57. One of a pharmaceutical composition and kit comprising:
(i) an agent in an amount effective to cause blood glutathione
levels to increase, selected from the group consisting of
glutathione, N-acetyl cysteine, 2-oxo-4 thiazolidine
carboxylic acid, ebselen, oltipraz, L-cysteine, N-acetyl
cysteine ethyl ester, N-acetyl cysteine methyl ester,
cystamine, cysteamine, penicillamine, 2,3 dimercapto-1-
propanol, L-2-oxothiazolidone-4-carboxylate, dimethyl
maleate, glutathione ethyl ester, glutathione methyl ester,
Page: 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007